Randomized placebo-controlled study of lovastatin in children with neurofibromatosis type 1
Jonathan M Payne, Belinda Barton, Nicole J Ullrich, Alan Cantor, Stephen JC Hearps, Gary Cutter, Tena Rosser, Karin S Walsh, Gerard A Gioia, Pamela L Wolters, James Tonsgard, Elizabeth Schorry, David Viskochil, Laura Klesse, Michael Fisher, David H Gutmann, Alcino J Silva, Scott J Hunter, Celiane Rey-Casserly, Nancy L Cantor Show all
Neurology | LIPPINCOTT WILLIAMS & WILKINS | Published : 2016
Awarded by US Army Medical Research and Materiel Command, Office of the Congressionally Directed Medical Research Programs, Department of Defense Neurofibromatosis Research Program
This work was supported by the US Army Medical Research and Materiel Command, Office of the Congressionally Directed Medical Research Programs, Department of Defense Neurofibromatosis Research Program, grant W81XWH-05-1-0615. The funding source reviewed and approved the protocol. It had no role in the conception and design of the study; collection, management, analysis, or interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. The work was also partially funded by Sally Gottesman and Rachel B. Tiven.